Mortality Outcome of Controlled Hypertension

Inclusion criteria * Human studies (RCTs, cohort, case-control, registry studies, etc.) declare participants with treated and controlled hypertension manage (regardless of drug class, duration, or comorbidity) reported mortality outcomes: all-vascular death, cardiovascular death, sudden death, etc. * Studies in any setting (outpatient, inpatient, long-term follow-up) * Articles in English * Full-text available Exclusion criteria * Animal specimen or parameter studies * Uncontrolled studies (e.g., case series without control, phase I safety trials) * No mortality endpoint reported * Purely mechanistic studies or trials that do not address BP or survival directly * Pediatric studies unless separated subgroup for treated hypertension is available * Glaucoma or portal hypertension or Pulmonary Hypertension without essential/systemic hypertension outcomes * Infection without direct declare that septic shock or immunological failure associated by vascular cause from systemic hypertension * Secondary/post-hoc analyses that do not report original mortality data